RESUMEN
Enalapril is an orally administered angiotensin-converting enzyme inhibitor which is widely prescribed to treat hypertension, chronic kidney disease, and heart failure. It is an ester prodrug that needs to be activated by carboxylesterase 1 (CES1). CES1 is a hepatic hydrolase that in vivo biotransforms enalapril to its active form enalaprilat in order to produce its desired pharmacological impact. Several single nucleotide polymorphisms in CES1 gene are reported to alter the catalytic activity of CES1 enzyme and influence enalapril metabolism. G143E, L40T, G142E, G147C, Y170D, and R171C can completely block the enalapril metabolism. Some polymorphisms like Q169P, E220G, and D269fs do not completely block the CES1 function; however, they reduce the catalytic activity of CES1 enzyme. The prevalence of these polymorphisms is not the same among all populations which necessitate to consider the genetic panel of respective population before prescribing enalapril. These genetic variations are also responsible for interindividual variability of CES1 enzyme activity which ultimately affects the pharmacokinetics and pharmacodynamics of enalapril. The current review summarizes the CES1 polymorphisms which influence the enalapril metabolism and efficacy. The structure of CES1 catalytic domain and important amino acids impacting the catalytic activity of CES1 enzyme are also discussed. This review also highlights the importance of pharmacogenomics in personalized medicine.
RESUMEN
Visible active mixed metal ferrite intercalated semiconductor photocatalyst Mn0.6Zn0.4Fe2O4/g-C3N4was prepared via facile hydrothermal and liquid assembly method for methylene blue (MB) dye degradation. The prepared samples were well characterized in term of their functional groups, crystallinity, elemental analysis, surface morphology using Fourier transform infrared spectroscopy, x-ray diffraction spectroscopy, energy dispersive x-ray, and scanning electron microscopy, respectively. The optical response of catalysts was checked by estimating the energy band gap (Eg) of semiconductor photocatalysts using UV-vis spectroscopy. The photoluminescence spectroscopy was also performed to estimate the reduction in emission intensity after insertion of g-C3N4into Mn0.6Zn0.4Fe2O4.The novel composition of Mn0.6Zn0.4Fe2O4with g-C3N4,improved the optical response of pristine photocatalysts due to the reduction in the energy band gap and insertion of heterojunction. The surface area analysis of Mn0.6Zn0.4Fe2O4and Mn0.6Zn0.4Fe2O4/g-C3N4were acquired by Brunauer-Emmett-Teller. Point zero charge was also determined to observe the surface behavior of composite under different solution pH. Various parameters such as pH, catalyst dose, oxidant dose, irradiation time and initial dye concentration were optimized, and their effects were studied in photo-Fenton process. It was observed that 98% MB dye was degraded under optimized conditions (pH = 8, composite dose = 50 mg/100 ml, oxidant dose = 7 mM, initial dye conc. = 10 ppm, and irradiation time = 120 min). The results showed that when the ferrites of mixed metals (Mn, Zn) were used with g-C3N4their photocatalytic activity enhanced due to mutual effect of both mixed metals ferrite and g-C3N4, which is considerably higher than their individual effect already reported. Furthermore, the combined effect of independent variables was evaluated by response surface methodology.
